|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash stock-based compensation expense | |||||
| Impairment of fixed assets | |||||
| Loss on sale of assets | |||||
| Gain on disposal of business | |||||
| Deferred income taxes | |||||
| Net gains on investment securities | |||||
| Equity in (earnings) losses from equity-method investments | |||||
| Distributions from equity-method investments | |||||
| Non-cash interest expense | |||||
| Non-cash lease expense | |||||
| Change in fair value of contingent liability | |||||
| Change in fair value of the derivative embedded within convertible debt | |||||
| Provision for credit losses | |||||
| Loss on extinguishment of liability | |||||
| Changes in assets and liabilities: | |||||
| Receivables | |||||
| Income taxes receivables, net | |||||
| Contract assets, net | |||||
| Accounts payable and accrued liabilities | |||||
| Operating right-of-use assets and operating lease liabilities, net | |||||
| Accrued salary and benefits | |||||
| Contract liabilities | |||||
| Antitrust litigation settlement | |||||
| Other assets and liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Investments in equity-method investments | |||||
| Distributions from equity-method investments | |||||
| Purchase of debt securities | |||||
| Purchase of equity securities | |||||
| Proceeds from sale or liquidation of long-term investments | |||||
| Purchase of long-term investments | |||||
| Purchase of subsidiaries | |||||
| Proceeds from sale or liquidation of short-term investments | |||||
| Purchase of short-term investments | |||||
| Purchase of investment securities at fair value | |||||
| Proceeds from disposal of business, less cash distributed | |||||
| Capital expenditures | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from debt issuance | |||||
| Repayment of debt | |||||
| Contributions from Former Parent | |||||
| Distributions to Former Parent | |||||
| Repayments of convertible note | |||||
| Deferred financing charges | |||||
| Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting | |||||
| Dividends on common stock | |||||
| Contributions from non-controlling interest | |||||
| Earn out payments | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...